Healthcare Technologies to deploy World ID at 3,000 sites
Healthcare Technologies Inc. filed a Form 6-K after entering a Master Service Agreement with Tools for Humanity and the World Foundation to support adoption of World ID in Japan.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Healthcare Technologies Inc. filed a Form 6-K after entering a Master Service Agreement with Tools for Humanity and the World Foundation to support adoption of World ID in Japan. The company plans to deploy Orb authentication devices across approximately 3,000 locations nationwide, a major expansion from an initially planned 100 locations.
Within its existing operations, Orbs are already installed at more than 150 Re.Ra.Ku wellness centres, with a goal of reaching about 300 centres across the Re.Ra.Ku Group. Beyond company-operated sites, Healthcare Technologies is negotiating with 370 third-party locations and intends to use a standard framework for contracts, branding, privacy protection, and quality control so authentication services are delivered consistently across partner locations.
Insights
Healthcare Technologies is scaling a World ID rollout via a large Japan-wide location network.
The company has entered a Master Service Agreement with Tools for Humanity and the World Foundation to deploy Orb devices for World ID across approximately 3,000 locations in Japan. This is described as a significant scale-up from an initially planned 100 locations, suggesting a much broader operational commitment to digital identity services than originally contemplated.
Execution will leverage existing wellness centres and external partners. Orbs are already installed at more than 150 Re.Ra.Ku Group wellness centres, with a target of about 300 centres, while negotiations are underway with 370 third-party locations within a broader 3,000-location partner network. Outcomes will depend on how many partners ultimately participate and how quickly locations go live, which is not specified in the disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January, 2026
Commission File Number 001-39809
MEDIROM HEALTHCARE TECHNOLOGIES INC.
(Translation of registrant’s name into English)
2-3-1 Daiba, Minato-ku
Tokyo 135-0091, Japan
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
☒ Form 20-F ☐ Form 40-F
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
Issuance of Press Release
On January 23, 2026, MEDIROM Healthcare Technologies Inc. (the “Company”) entered into a Master Service Agreement with Tools for Humanity and the World Foundation to accelerate the adoption of World ID in Japan by deploying Orb authentication devices across approximately 3,000 locations nationwide. This initiative represents a significant scale-up from the initially planned 100 locations and marks a key milestone in the Company’s growth strategy.
The information furnished in this report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, as amended, except to the extent specifically provided in such a filing.
EXHIBIT INDEX
Exhibit No. | | Description |
99.1 | | Press release of the Company |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| MEDIROM HEALTHCARE TECHNOLOGIES INC. | |
Date: January 23, 2026 | | |
| By: | /s/ Fumitoshi Fujiwara |
| | Name: Fumitoshi Fujiwara |
| | Title: Chief Financial Officer |
Exhibit 99.1
MEDIROM Forms New Special Mission Team
to Drive World ID Adoption Across 3,000 Locations
Through Partnership with Tools for Humanity
MEDIROM Healthcare Technologies Inc.(Headquarters: Minato-ku, Tokyo; President and CEO: Kouji Eguchi; listed on Nasdaq: NASDAQ: MRM, hereinafter “MEDIROM”), a company engaged in diversified healthcare businesses, has entered into a Master Service Agreement (the “MSA”) with Tools for Humanity (“TFH”) and the World Foundation (“WF”), and will support World ID adoption with the installation of Orbs across 3,000 locations nationwide in Japan.
Tools for Humanity was co-founded by Sam Altman and Alex Blania and led the initial development of the World Project. The Orb is a device that allows an individual to verify that they are a unique human, and create a secure and anonymous World ID on their phone.
To promote the nationwide adoption of World ID and deploy Orb authentication terminals across approximately 3,000 locations throughout Japan, we plan to advance nationwide coverage primarily through the following two channels.
1. Expansion within the Re.Ra.Ku Group
Currently, Orbs are installed at more than 150 wellness centres operated by the MEDIROM Group, primarily under the “Re.Ra.Ku” brand.
Going forward, we plan to expand deployment to franchised locations as well, with the aim of installing Orbs at approximately 300 wellness centres across the entire Re.Ra.Ku Group.
Re.Ra.Ku service website: https://reraku.jp/
2. MEDIROM Management Partner Network of Approximately 3,000 Locations
In addition to MEDIROM-operated locations, we plan to collaborate with member stores of the Japan Relaxation Industry Association, as well as other retail and service providers, to expand deployment to approximately 3,000 locations nationwide.
We are currently in negotiations with 370 such third-party locations.
Each partner will participate based on MEDIROM’s standard operating framework, which covers areas such as contracts, branding, privacy protection, and quality control, and will provide authentication services with consistent and standardized quality.
■ About Tools for Humanity
Tools for Humanity (TFH) is a global technology company established to build for humans in the age of AI. Founded by Sam Altman and Alex Blania, it led the initial development of World Network and operates World App. Tools for Humanity Corporation is headquartered in San Francisco, California and Munich, Germany. To learn more, visit: toolsforhumanity.com
■ About MEDIROM Group
MEDIROM Group operates approximately 300 wellness salons under the “Re.Ra.Ku®” brand nationwide. Since 2015, we have expanded into HealthTech, offering on-demand training apps like Lav® for specific health guidance and lifestyle improvement programs. In 2020, we started manufacturing the 24/7 recharge-free smart tracker “MOTHER Bracelet®,” which is now used in REMONY, our remote monitoring system for various industries including caregiving, transportation, construction, and manufacturing.
About MEDIROM Healthcare Technologies Inc.
NASDAQ Symbol: MRM
Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan
Website: https://medirom.co.jp/en
Contact: ir@medirom.co.jp
■ Forward-Looking Statements Regarding MEDIROM
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “designate,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include:
| ● | A third party entering into a letter agreement with TFH and WF and the MSA becoming effective; |
| ● | MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives, including the full-scale adoption of World ID and deployment of Orb authentication terminals across 3,000 locations , and achieving its targeted number of verifications; |
| ● | the MSA being early terminated by the World parties for convenience or any other reason; |
| ● | Changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets; |
| ● | MEDIROM’s ability to achieve and sustain profitability in its Digital Preventative Healthcare Segment; |
| ● | the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies; |
| ● | MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property; |
| ● | MEDIROM’s ability to raise additional capital on acceptable terms or at all; |
| ● | MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments; |
| ● | changes in consumer preferences and MEDIROM’s competitive environment; |
| ● | MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and |
| ● | the regulatory environment in which MEDIROM operates. |
More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov. MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future.